OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-09-30-accounts

Reference and Administrative
Details
Trustees'
Report
2to5
Independent
Examiner's
Report
6to 7
Consolidated
Statement
of Financial
Activities
Consolidated
Balance Sheet
Balance Sheet 10
Consolidated
Statement
ofCash Flows
Notes to the Financial Statements 12to 25

Total Recognised
G
ains and Loss
es)
Unrestricted Restricted Total Total
funds funds 2022 2021
Note E f. F
Income and Endowments from:
Donations
and legacies
2 6,190 6,190 9,626
Other trading
activities
3 289,426 289,426 202,161
Investment
income
4 1,614 1,614 224
Other income 5 34,689
Total income 297,230 297,230 246,700
Expenditure
on:
Raising funds (217,175) (217,175) (178,555)
Charitable
activities
Other expenditure
(77,563)
~(725
(77,563)
(725
(109,922)
(689
Total expenditure (295,463) (295,463 (289,166)
Net income/(expenditure) 1,767 1,767 (42,466
Net movement
in funds
1,767 1,767 (42,466)
Reconciliation
offunds
Total funds brought forward 505,029 440 505,469 547,935
Total funds carried forward tg 506,796 440 507,236 505,469

C o nsolidated
Salance Sheet a
s at 30Sept ember 2022
2022 2021
Note
Fixed assets
Tangible assets 13 1,059 2,032
Current assets
Stocks
Debtors
Cash at bank and
in hand 15 11,628
15,565
505,948
12,011
8,948
499,688
533,141 520,647
Creditors: Amounts falling due within one year 16 (26,964) (17,210)
Net current assets 506,177 503,437
Net assets 507,236 505,469
Funds ofthe group:
Restricted
income
funds
Restricted
funds
440 440
Unrestricted
income
funds
Unrestricted
funds
506,796 505,029
Total funds 19 507,236 505,469

2022 2021
Note f.
Fixed assets
Investments 100 100
Current assets
Debtors
Cash at bank and
in hand 15 74,509
439,646
61,423
448,972
514,155 510,395
Creditors: Amounts falling due within one year 16 (3,540) (2,520)
Net current assets 510,615 507,875
Net assets 510,715 507,975
Funds ofthe charity:
Restricted income funds
Restricted funds 440 440
Unrestricted income funds
Unrestricted funds 510,275 507,535
Total funds 510,715 507,975

Consolidated
Statemen
t ofCash F lows for the Year En ded 30Septem ber
2022
2022 2021
Note f.
Cash flows from operating activities
Net cash income/(expenditure) 1,767 (42,466)
Adjustments
to cash flows
from noncash items
Depreciation 1,453 1,446
Investment
income
1,614 224
1,606 (41,244)
Working capital adjustments
Decrease/(increase)
in stocks
Increase
in debtors
Increase/(decrease)
in creditors
15
16
383
(6,617)
9,754
(423)
(4,151)
451
Net cash flows from operating activities 5,126 46,269
Cash flows from investing
activities
Interest receivable
and similar
income 4 1,614 224
Purchase oftangible
fixed assets
13 (480) (978)
Net cash flows from investing activities 1,134 754
Net increase/(decrease)
in cash and cash equivalents
6,260 (47,023)
Cash and cash equivalents
at
1 October 499,688 546,711
Cash and cash equivalents
at
30 September 505,948 499,688

2
Income
from donati ons
and legacies
Unrestricted
funds Total Total
General 2022 2021
E
Donations
and legacies;
Donations and gifts 4,568 4,568 5,514
Legacies and funeral donations 762 762 2,980
Income tax and gift aid 860 860 1,132
6,190 6,190 9,626

3
Inco
me fro m othe r trading activities
Unrestricted
funds Total Total
General 2022 2021
Trading income;
Commercial trading operations 288,689 288,689 202,156
Events income;
Other events income 737 737
289,426 289,426 202,161

Unrestricted
funds Total Total
General 2022 2021
F
Other investment income 1,614 1,614 224

Total Total
2022 2021
F F
Other operating
CJRS income
income 1,082
3,931
Insurance payout 29,676
34,689

Unrestricted
funds Total Total
General 2022 2021
E
Fund-raising and publicity 175 175

b) Cos ts oftradin g
activities
Unrestricted
funds Total Total
Note General
f
2022 2021
Trading subsidiary costs 11 217,000 217,000 178,555
217,000 217,000 178,555

7
Expen
di ture
on charitable
activit
ies
Unrestricted
funds Total Total
General 2022 2021
Note
Support to Patients 735 735
Allocated support costs 725 725 689
Governance costs 3,710 3,710 2,520
Donations to YDH NHS Foundation
Trust 73,118 73,118 107,402
78,288 78,288 110,611

Suppo rt costs allocated to charitable
activities
Other
support Total Total
Basis of costs 2022 2021
allocation K
Attend subscription 100%support 725 725 689

Unrestricted
funds Total Total
General 2022 2021
F f.
Independent examiner fees
Examination
Other fees
ofthe financial statements
paid to examiners
1,525
2,185
1,525
2,185
1,380
1,140
3,710 3,710 2,520
9 Net incoming/outgoing resources
Net incoming/(outgoing)
resources for the year include:
2022 2021
Independent
Depreciation
examiner's
fees
offixed assets
3,710
1,453
2,520
1,446

Sbid
i
usary
Pr
t and Loss 2022 2021
Turnover 288,689 202,156
Cost ofsales (172,522) (125,753)
Gross profit 116,167 76,403
Other operating income 347 35,952
Administrative expenses (44,478) (52,802)
Net Profit 72,036 59,553
Reserves
brought
forward
57,515 59,467
Distribution
to The League ofFriends ofYeovil Hospitals
(60,021) (61,505)
Retained
in Subsidiary
The assets and liabilities ofthe subsidiary were 2022 2021
E
Fixed assets 1,059 2,032
Current assets 91,995 70,273
Current
liabilities
(23,424) (14,690)
Total net assets 69,630 57,615
Share capital 100 100
Reserves 69,530 57,515
Total equity 69,630 57,615

12Staffcosts 12Staffcosts 12Staffcosts
The aggregate
payroll costs were as follows:
2022 2021
f.
Staffcosts during the year were:
Wages and salaries 35,615 43,079
Staff pensions
(defined
contribution) 1,366 1,360
36,981 44,439
The average
number ofpersons
employed
during the year was as follows:

Group
Fixtures and Office
fittings equipment Total
E
Cost
At 1 October 2021 13,915 978 14,893
Additions
Disposals
480
559
480
~(559
At 30September 2022 13,836 978 14,814
Depreciation
At 1 October 2021 12,665 196 12,861
Charge for the year
Eliminated
on disposals
1,297
559
156 1,453
~559
At 30September 2022 13,403 352 13,755
Net book value
At 30September 2022 433 626 1,059
At 30September 2021 1,250 782 2,032

Subsidiary
undertakings Total
E
Cost
At 1 October 2021 100 100
At 30September 2022 100 100
Net book value
At 30September 2022 100 100
At 30 September 2021 100 100

15Debtors
Group
2022
2021 2022 Charity 2021
E F
Prepayments 265 265
Accrued income 375 3 73,384 60,024
Other debtors 14,925 8,945 860 1,399
15,565 8,948 74,509 61,423

16Creditors: amounts
falling
due within one year
Group
2022
2021 2022
Charity
2021
F F F
Trade creditors 15,218 8,545
Other taxation and social
security 359 668
VAT payable 4,222 2,188
Other creditors 1,241 1,310
Accruals 5,924 4,499 3,540 2,520
26,964 17,210 3,540 2,520

Group
Balance at
Balance at 30
1 October
2021
f.
Incoming
resources
E
Resources
expended
Transfers September
2022
Unrestricted
funds
General
Unrestricted
general
funds 169,771 297,230 (267,601) (140,520) 58,880
Designated
Children's
outpatients
300,000 (150,000) 150,000
Breast Cancer Unit 100,000 100,000
New projects
Other designated
funds 35,258 ~27,662 150,000
40,520
150,000
47,916
335,258 (27,862) 140,520 447,916
Total unrestricted funds 505,029 297,230 ~(295,463 506,796
Restricted funds
Chemotherapy
unit
66 66
Macmillan
unit Barrie
Ackland 85 85
Ward 8BDaphne I Tulk 175 175
Macmillan
unit John Hicks
114 114
Total restricted funds 440 440
Total funds

Notes to the Financial Statements
for
the Year End ed 30Septem ber 2022
Balance at 1
October 2020
Incoming
resources
Resources
expended
Balance at 30
September
2021
F
Unrestricted
funds
General
Unrestricted
general funds
163,246 246,700 (240,175) 169,771
Designated
Children's
outpatients
Other designated
funds
300,000
83,624
(48,366) 300,000
35,258
383,624 48,366 335,258
Total unrestricted
funds
546,870 246,700 (288,541 505,029
Restricted funds
Chemotherapy
unit
66 66
Macmillan
unit Barrie Ackland
Ward 8BDaphne
I Tulk
85
175
85
175
Mrs H M Ward patients
vouchers
for shop
Macmillan
unit John Hicks
625
114
(625) 114
Total restricted
funds
1,065 (625 440
Total funds 547,935 246,700 (289,166 505,469

Group
Total funds
Unrestricted at 30
funds
General
Restricted
funds
September
2022
E
Tangible
Current
Current
fixed assets
assets
liabilities
1,059
532,701
26,964
440 1,059
533,141
26,964
Total net assets 506,796 440 507,236
Total funds
Unrestricted at 30
funds
General
Restricted
funds
September
2021
Tangible
Current
Current
fixed assets
assets
liabilities
2,032
520,207
17,210
440 2,032
520,647
17,210)
Total net assets 505,029 440 505,469